Jo Wallis

Jo Wallis is an experienced HTA and Market Access expert with over 20 years in the Life Sciences industry, currently serving as Head of Commercialisation and Pricing Strategy at SCIRIS. Formerly, they held positions including Vice President at MAP Patient Access Limited and Clinical Effectiveness Consultant at Pfizer, where they focused on rare diseases and clinical effectiveness. Jo has a strong background in leadership, health economics, and market access strategies, complemented by a BSc in Psychology from the University of Gloucestershire and a Post Graduate Certificate in Health Economic Evaluation from the University of York. They are dedicated to supporting Biotech and Pharma companies in early launch planning and pricing strategy.